Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650266 | 0.86 | MEN1 (0.40) | BRD4PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL22650274 | 0.84 | KDR (0.40) | BRD4PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL22650271 | 0.83 | MAPT (0.37) | BRD4PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL15049243 | 0.79 | PTGS1 (0.46) | BRD4PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL16232517 | 0.79 | PTGS1 (0.46) | BRD4PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL22650233 | 0.74 | MEN1 (0.48) | MEN1KMT2A | |
| SCHEMBL25925933 | 0.68 | PTGS1 (0.41) | BRD4PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL18250390 | 0.66 | KMT2A (0.49) | BRD4MEN1KMT2A | |
| SCHEMBL22754696 | 0.63 | MEN1 (0.35) | BRD4PTGS1PTGS2MEN1KMT2A | |
| SCHEMBL13505630 | 0.62 | INSR (0.54) | BRD4PTGS1PTGS2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200354576-A1 | DYEING COMPOSITION, DYED PRODUCT, AND AZO COLORING AGENT | FUJIFILM CORPORATION (JP) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354576-A1 | DYEING COMPOSITION, DYED PRODUCT, AND AZO COLORING AGENT | CYP1B1, CYP1A1, NAT1 | RPS6KB2 2972/4885BRD4 2321/4885PTGS1 1164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.